Interestingly, RSK inhibition by PMD-026 or BI-D1870 increased expression on the major histocompatibility complex (MHC) class 1 (MHC-1), and downregulation of MHC-1 is associated with tumor immunity (Balasubramanian et al., 2022). The gene discussed is RPS6KA3; the disease is neoplasm.